Safety and short-term efficacy of neoadjuvant FLOT therapy in cisplatin-unfit patients with resectable esophageal squamous cell carcinoma
Neoadjuvant FLOT demonstrated manageable safety profiles and promising efficacy in patients with resectable LA-ESCC who were CDDP-unfit.
Authors
- Yuri Yoshinami
- Daisuke Kurita (ORCID: https://orcid.org/0000-0002-4243-3969)
- Junya Oguma (ORCID: https://orcid.org/0000-0002-3865-0514)
- Hiroshi Imazeki
- Kazuki Yokoyama
- Yoshitaka Honma (ORCID: https://orcid.org/0000-0002-4209-4493)
- Shun Yamamoto (ORCID: https://orcid.org/0000-0002-9065-781X)
- Taiki Hashimoto (ORCID: https://orcid.org/0000-0003-3148-9243)
- Ken Kato (ORCID: https://orcid.org/0000-0002-1733-5072)
- Hiroyuki Daiko (ORCID: https://orcid.org/0000-0002-9562-2966)
- Tairo Kashihara (ORCID: https://orcid.org/0000-0002-2471-605X)
- Koshiro Ishiyama
- Kazuhiro Shiraishi (ORCID: https://orcid.org/0009-0004-3131-1829)
Institutions
- National Cancer Center (US)
- Tokyo National Hospital (JP)
Publication Details
- Journal
- Esophagus
- Published
- 2025-10-14
- DOI
- https://doi.org/10.1007/s10388-025-01160-5
- Primary Topic
- Esophageal Cancer Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00